Sign In
Buy GMDA
$0.0327
+0 (+0%)
At Close: Aug 27, 2024
Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
01:01pm, Tuesday, 26'th May 2020
Gamida Cell announced full exercise of underwriters' option to purchase an additional 2,000,000 shares.
Gamida Cell (GMDA): Strong Industry, Solid Earnings Estimate Revisions
12:50pm, Tuesday, 26'th May 2020
Gamida Cell (GMDA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Top Ranked Momentum Stocks to Buy for May 22nd
02:58pm, Friday, 22'nd May 2020
Top Ranked Momentum Stocks to Buy for May 22nd
3 “Strong Buy” Biotech Stocks Under $5 With Massive Upside Potential
01:22pm, Thursday, 21'st May 2020
Is it May 2020 or March 2009? As Wall Street observers traverse the confused economic environment, flashbacks of the Great Recession are coming to mind. Those looking at the glass half empty will poin
Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update
12:01pm, Thursday, 21'st May 2020
Gamida Cell today announced financial results for the first quarter of 2020 and provided a company update.
8 Biotechs Tapping Secondary Markets for $3 Billion
10:53pm, Tuesday, 19'th May 2020
Company stocks drop on dilution, but monies could benefit shareholders down the line Continue reading...
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
02:40am, Tuesday, 19'th May 2020
Gamida Cell today announced the pricing of a $60 million public offering of ordinary shares.
Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares
08:01pm, Monday, 18'th May 2020
Gamida Cell today announced the launch of a proposed public offering of ordinary shares.
Here's Why We're Watching Gamida Cell's (NASDAQ:GMDA) Cash Burn Situation
01:02pm, Sunday, 17'th May 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Company News for May 13, 2020
02:12pm, Wednesday, 13'th May 2020
Companies In The News Are: GMDA, NNVC, CHAP, YRCW
Gamida Cell announced positive results from its Phase 3 clinical study evaluating omidubicel for bone marrow transplant.
Fly Intel: Top five analyst initiations FGEN;SLRX;GMDA;KRUS;CYCC
02:39pm, Monday, 27'th Apr 2020
Fly Intel: Top five analyst initiations FGEN SLRX GMDA KRUS CYCC
JPMorgan construction analysts to hold an amalyst/industry conference call
02:38pm, Monday, 27'th Apr 2020
JPMorgan construction analysts to hold an amalyst/industry conference call
JPMorgan basic materials analysts to hold an analyst/industry conference call
02:38pm, Monday, 27'th Apr 2020
JPMorgan basic materials analysts to hold an analyst/industry conference call
Mid-Day Market Update: Crude Oil Down 3%; Applied DNA Sciences Shares Jump
04:01pm, Wednesday, 15'th Apr 2020
Midway through trading Wednesday, the Dow traded down 2.63% to 23319.37 while the NASDAQ fell 1.99% to 8346.64. The S&P also fell, dropping 2.73% to 2,768.24.
The U.S. is the...
